In December, the board had approved repurchasing $217 million of the company’s stock, or about 1.2 percent of the company’s outstanding shares.
In a news release, CEO Neal Patterson reiterated the repurchasing would be a good use of company funds, indicating he expects Cerner to continue the strong growth that characterized the company’s past two quarters.
“This program reflects our commitment to enhancing long-term shareholder value and our confidence in Cerner’s prospects as a leader in the growing healthcare industry,” said Mr. Patterson in the release.
More Articles on Cerner:
5 Takeaways From Cerner’s Annual Shareholders’ Meeting
7 Executives on Why They Selected Their Current EHR Vendor
4 Health IT Companies That Posted Increased Revenues in Q1
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
